EIDX - Eidos Therapeutics EPS misses by $0.12 October, 29 2020 05:01 PM Eidos Therapeutics Inc. Eidos Therapeutics (EIDX): Q3 GAAP EPS of -$0.79 misses by $0.12.Revenue of $0.13M (-99.5% Y/Y)Cash and cash equivalents of $147.3M.Press Release For further details see: Eidos Therapeutics EPS misses by $0.12